People: Sanofi SA (SASY.PA)
Mr. Andrew S. Plump has served as Vice President, Research & Translational Medicine and Deputy to the President of Global R&D and Member of the Global Leadership Team of Sanofi SA since July 2012. He received a Doctorate of Medicine (M.D.) degree from the University of California, San Francisco and obtained a Doctorate in Philosophy (Ph.D.) degree in Cardiovascular Genetics from The Rockefeller University. He also earned a Bachelor of Science degree (B.S.) from the Massachusetts Institute of Technology. He completed a residency in Internal Medicine and a Fellowship in Medical Genetics at U.C.S.F. Following his clinical training, he trained as a Howard Hughes postdoctoral fellow with Dr. Marc Tessier-Lavigne in the department of Anatomy and Neuroscience at U.C.S.F., after which he assumed faculty responsibilities as an Adjunct Clinical Instructor in the department of Medical Genetics. Mr. Plump joined Sanofi SA after eleven years in the pharmaceutical industry where he held various positions at Merck, initially as Director in the Department of Clinical Pharmacology and subsequently in Clinical Molecular Profiling and subsequently as Vice President and head of translational medicine and discovery in the Cardiovascular Disease Franchise. In the Cardiovascular Franchise at Merck Andrew was responsible for the Merck Cardiovascular Early Development, Translational Medicine and Discovery portfolios. In this role, he led the discovery and advancement of several programs in the Merck portfolio.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|